• 英文タイトル:Genomics Market Research Report by Product & Service, Technology, End-User, Application, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

Genomics Market Research Report by Product & Service, Technology, End-User, Application, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19「ゲノミクスの世界市場(~2027)」(市場規模、市場予測)調査レポートです。• レポートコード:MRC2301G093
• 出版社/出版日:360iResearch / 2022年10月
• レポート形態:英語、PDF、226ページ
• 納品方法:Eメール(受注後2-3日)
• 産業分類:化学
• 販売価格(消費税別)
  Single User(1名利用、印刷可)¥742,350 (USD4,949)▷ お問い合わせ
  Enterprise License(企業利用、印刷可)¥1,492,350 (USD9,949)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
360iResearch社は、世界のゲノミクス市場規模が、2021年の233.1億ドルから2022年には271億ドルへ増加し、2027年までにCAGR 16.39%拡大して579.9億ドルまで成長すると予測しています。本書では、ゲノミクスの世界市場を調査対象とし、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、製品・サービス別(消耗品、サービス、システム・ソフトウェア)分析、技術別(マイクロアレイ、核酸抽出・精製、PCR、シーケンシング)分析、エンドユーザー別(病院・診療所、製薬・バイオテクノロジー企業、研究センター・学術・政府機関)分析、用途別(農業・動物研究、診断、創薬・開発)分析、地域別(南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他)分析、競争状況、企業情報などの内容を整理しました。また、本書に記載されている企業情報には23andMe, Inc.、Agilent Technologies, Inc.、Beijing Genomics Institute (BGI)、Bio-Rad Laboratories, Inc.、Danaher Corporation、Eppendorf AG、Eurofins Scientific、F. Hoffmann-La Roche Ltd.、Helix OpCo, LLC、Illumina, Inc.、IntegraGen SAなどが含まれています。
- ゲノミクス消耗品の市場規模
- ゲノミクスサービスの市場規模
- ゲノミクスシステム・ソフトウェアの市場規模
- マイクロアレイにおける市場規模
- 核酸抽出・精製における市場規模
- PCRにおける市場規模
- シーケンシングにおける市場規模
- 病院・診療所における市場規模
- 製薬・バイオテクノロジー企業における市場規模
- 研究センター・学術・政府機関における市場規模
- 農業・動物研究における市場規模
- 診断における市場規模
- 創薬・開発における市場規模
- 南北アメリカのゲノミクス市場規模
- アジア太平洋のゲノミクス市場規模
- ヨーロッパ/中東/アフリカのゲノミクス市場規模
- その他地域のゲノミクス市場規模

The Global Genomics Market size was estimated at USD 23.31 billion in 2021 and expected to reach USD 27.10 billion in 2022, and is projected to grow at a CAGR 16.39% to reach USD 57.99 billion by 2027.

Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:
This research report categorizes the Genomics to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product & Service, the market was studied across Consumables, Services, and Systems & Software.

Based on Technology, the market was studied across Microarray, Nucleic Acid Extraction & Purification, PCR, and Sequencing.

Based on End-User, the market was studied across Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, and Research Centers and Academic & Government Institutes,.

Based on Application, the market was studied across Agriculture & Animal Research, Diagnostics, and Drug Discovery & Development.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Genomics market considering the current update on the conflict and its global response.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Genomics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Genomics Market, including 23andMe, Inc., Agilent Technologies, Inc., Beijing Genomics Institute (BGI), Bio-Rad Laboratories, Inc., Danaher Corporation, Eppendorf AG, Eurofins Scientific, F. Hoffmann-La Roche Ltd., Helix OpCo, LLC, Illumina, Inc., IntegraGen SA, Merck Group, Myriad Genetics, Inc., Novogene Co., Ltd., Oxford Nanopore Technologies, Pacific Biosciences of California, Inc., Personal Genome Diagnostics Inc., Personalis, Inc., Quest Diagnostics Incorporated, and Thermo Fisher Scientific Inc..

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Genomics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Genomics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Genomics Market?
4. What is the competitive strategic window for opportunities in the Global Genomics Market?
5. What are the technology trends and regulatory frameworks in the Global Genomics Market?
6. What is the market share of the leading vendors in the Global Genomics Market?
7. What modes and strategic moves are considered suitable for entering the Global Genomics Market?


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers Rising number of government genome projects Growing adoption of genomic medicine Development of genetic tools in agrigenomics
5.1.2. Restraints High cost of equipment and consumables
5.1.3. Opportunities Growth of newborn genetic screening programs Adoption of sequencing and innovative product launch and services
5.1.4. Challenges Limited skilled and trained personnel
5.2. Cumulative Impact of COVID-19

6. Genomics Market, by Product & Service
6.1. Introduction
6.2. Consumables
6.3. Services
6.4. Systems & Software

7. Genomics Market, by Technology
7.1. Introduction
7.2. Microarray
7.3. Nucleic Acid Extraction & Purification
7.4. PCR
7.5. Sequencing

8. Genomics Market, by End-User
8.1. Introduction
8.2. Hospitals & Clinics
8.3. Pharmaceutical & Biotechnology Companies
8.4. Research Centers and Academic & Government Institutes,

9. Genomics Market, by Application
9.1. Introduction
9.2. Agriculture & Animal Research
9.3. Diagnostics
9.4. Drug Discovery & Development

10. Americas Genomics Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Genomics Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Genomics Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion

14. Company Usability Profiles
14.1. 23andMe, Inc.
14.1.1. Business Overview
14.1.2. Key Executives
14.1.3. Product & Services
14.2. Agilent Technologies, Inc.
14.2.1. Business Overview
14.2.2. Key Executives
14.2.3. Product & Services
14.3. Beijing Genomics Institute (BGI)
14.3.1. Business Overview
14.3.2. Key Executives
14.3.3. Product & Services
14.4. Bio-Rad Laboratories, Inc.
14.4.1. Business Overview
14.4.2. Key Executives
14.4.3. Product & Services
14.5. Danaher Corporation
14.5.1. Business Overview
14.5.2. Key Executives
14.5.3. Product & Services
14.6. Eppendorf AG
14.6.1. Business Overview
14.6.2. Key Executives
14.6.3. Product & Services
14.7. Eurofins Scientific
14.7.1. Business Overview
14.7.2. Key Executives
14.7.3. Product & Services
14.8. F. Hoffmann-La Roche Ltd.
14.8.1. Business Overview
14.8.2. Key Executives
14.8.3. Product & Services
14.9. Helix OpCo, LLC
14.9.1. Business Overview
14.9.2. Key Executives
14.9.3. Product & Services
14.10. Illumina, Inc.
14.10.1. Business Overview
14.10.2. Key Executives
14.10.3. Product & Services
14.11. IntegraGen SA
14.11.1. Business Overview
14.11.2. Key Executives
14.11.3. Product & Services
14.12. Merck Group
14.12.1. Business Overview
14.12.2. Key Executives
14.12.3. Product & Services
14.13. Myriad Genetics, Inc.
14.13.1. Business Overview
14.13.2. Key Executives
14.13.3. Product & Services
14.14. Novogene Co., Ltd.
14.14.1. Business Overview
14.14.2. Key Executives
14.14.3. Product & Services
14.15. Oxford Nanopore Technologies
14.15.1. Business Overview
14.15.2. Key Executives
14.15.3. Product & Services
14.16. Pacific Biosciences of California, Inc.
14.16.1. Business Overview
14.16.2. Key Executives
14.16.3. Product & Services
14.17. Personal Genome Diagnostics Inc.
14.17.1. Business Overview
14.17.2. Key Executives
14.17.3. Product & Services
14.18. Personalis, Inc.
14.18.1. Business Overview
14.18.2. Key Executives
14.18.3. Product & Services
14.19. Quest Diagnostics Incorporated
14.19.1. Business Overview
14.19.2. Key Executives
14.19.3. Product & Services
14.20. Thermo Fisher Scientific Inc.
14.20.1. Business Overview
14.20.2. Key Executives
14.20.3. Product & Services

15. Appendix
15.1. Discussion Guide
15.2. License & Pricing

• 英文レポート名:Genomics Market Research Report by Product & Service, Technology, End-User, Application, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
• 日本語訳:ゲノミクスの世界市場(~2027)
• レポートコード:MRC2301G093お問い合わせ(見積依頼・ご注文・質問)